How do I buy BillionToOne, Inc. Class A Common Stock (BLLN) stock?

Buying BillionToOne, Inc. Class A Common Stock (BLLN) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "BLLN", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy BLLN by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if BLLN is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

BillionToOne, Inc. Class A Common Stock (BLLN) Stock

Q: What is the minimum investment for BLLN on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in BillionToOne, Inc. Class A Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · BLLN

Trade BLLN

Key stats

Market cap: $5.27B
Price / Earnings ratio: 116.5x
EPS (TTM): $1.07
Volume: Loading
52-week high: $150.44
52-week low: $61.96
EPS vs analyst estimate: -37.5%Q3 FY25 · $0.10 vs $0.16

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with BLLN

Technical indicators

RSI 14: 51.72
MACD 12/26/9: 2.17
EMA 9 of MACD: 2.11
MACD histogram: 0.06
SMA 50: $106.59; Price above SMA 50
EMA 50: $107.79; Price above EMA 50
SMA 200: $97.41; Price above SMA 200
EMA 200: $99.80; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 5 analyst ratings

Strong Sell0

Sell0

Hold0

Buy5

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2023

2024

2025

366M242M121M0

Debt & Balance Sheet

Total assets

Total liabilities

2023

2024

2025

759M501M251M0

Revenue to Profit

2025

$305.1M

Revenue

$0.0

Cost of revenue

$208.5M

Gross profit

$0.0

Operating expenses

$7.5M

Net income

Earnings

EPS forecast

Actual EPS

$0.10

$0.16

Q3FY25

$0.13

Q1FY26

$0.07

Q2FY26

$0.03

Q3FY26

The market is expecting earnings per share of $0.03 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About BillionToOne, Inc. Class A Common Stock

BillionToOne is recognized for transforming healthcare through its redefinition of molecular diagnostics. The company’s revolutionary single-molecule NGS (smNGS) platform achieves what was once considered impossible — the detection and precise quantification of genetic targets with single-molecule sensitivity. At the core of this breakthrough is BillionToOne’s patented QCT technology, which enables measurements at the physical limit of detection — the single DNA molecule. This innovation directly addresses a long-standing challenge in healthcare: the difficulty of detecting sparse yet clinically critical disease signals in cell-free DNA (cfDNA).

SectorHealthcare

IndustryDiagnostics & Research

Employees713

CEODr. Oguzhan Atay Ph.D.

IPO DateNov 6, 2025

HeadquartersMenlo Park, CA

Key Executives

Name	Title	Year Born
Dr. Oguzhan Atay Ph.D.	Co-Founder, Chairman & CEO	1989
Mr. Ross Taylor Jr., M.B.A.	Chief Financial Officer	1963
Dr. David Tsao Ph.D.	Co-Founder, President, CTO & Director	1990
Mr. John D. Lister J.D.	Chief Administrative Officer	1975
Ms. Jean Hayden	VP of Business Operations & Chief of Staff	—
Mr. Thomas P. Lynch J.D.	Chief Compliance Officer, General Counsel & Secretary	1967
Ms. Nancy Johnson	Senior Vice President of Sales & Commercial Operations	1964
Ms. Jaclyn Eng	Vice President of Marketing	—
Mr. Vaghar Haghiri	Senior Director of People Operations	—
Ms. Shan Riku Sakakibara M.B.A.	Chief Product Officer	1984

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2025											+19.5	-27.6
2026	-7.6	-8.7	+0.4	-9.5	+27.7	+31.7	+13.3	-34.0	+15.3	+7.1	+1.4

Stocks in the same sector

Labcorp Holdings Inc.

FAQ

Buying BillionToOne, Inc. Class A Common Stock (BLLN) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "BLLN", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy BLLN by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in BillionToOne, Inc. Class A Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, BillionToOne, Inc. Class A Common Stock (BLLN) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track BLLN's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

BillionToOne, Inc. Class A Common Stock (BLLN) Stock

Key stats

Compare with BLLN

Recent news

BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth

BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth

BillionToOne SVP Sells 1,416 Shares

BillionToOne SVP Sells 1,416 Shares

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth

BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings Growth

BillionToOne SVP Sells 1,416 Shares

BillionToOne SVP Sells 1,416 Shares

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

Why BillionToOne Plummeted 36%, Leading A Medtech Sell-Off

Why BillionToOne Plummeted 36%, Leading A Medtech Sell-Off

BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say

BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say

Billiontoone Q2 Earnings Call Highlights

Billiontoone Q2 Earnings Call Highlights

A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84%

A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84%

Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?

Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

About BillionToOne, Inc. Class A Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade